Details werden geladen...
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
CAMBRIDGE, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on July 1, 2026, it awarded inducement grants to thirteen new employees under Intellia’s 2024 Inducement Plan, as amended, as a material inducement to employment.
Ähnliche Seiten
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2359852
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/20/tmt-newswire/globenewswire/camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2369284EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/16/tmt-newswire/globenewswire/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2366368Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/03/tmt-newswire/globenewswire/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2378068EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2346093